Amreen Husain, MD
Clinical Trials
- Not Recruiting Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma
- Not Recruiting Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
- Not Recruiting Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer
- Not Recruiting Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus
- Not Recruiting Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy
- Not Recruiting Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer
- Not Recruiting Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer
- Not Recruiting Second Curettage in Treating Patients With Persistent Non-Metastatic Gestational Trophoblastic Tumor
- Not Recruiting Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer
- Not Recruiting Clinical Trial for Ovarian Cancer (OvaRex®)
- Not Recruiting A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma
- Not Recruiting Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
- Not Recruiting Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients
Help
Trial Administration